Tilos Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
Tilos is a product-focused company developing anti-LAP antibodies for the treatment of cancer, with additional early efforts in fibrosis and autoimmune disease. Tilos is building on decades of work by its scientific founders in understanding the role of LAP-expressing cells in immune regulation to rapidly bring anti-LAP antibodies into clinical development.